Browsing by Author "Šobic-Šaranovic, Dragana (57202567582)"
Now showing 1 - 1 of 1
- Results Per Page
- Sort Options
- Some of the metrics are blocked by yourconsent settings
Publication Clinical value of immunoscintigraphy in the rectal carcinomas: Immunoscintigraphy of rectal carcinomas(2013) ;Petrović, Milorad (55989504900) ;Janković, Z. (56216490800) ;Jauković, Lj. (12769289900) ;Artiko, Vera (55887737000) ;Šobic-Šaranovic, Dragana (57202567582) ;Antić, Andrija (6603457520) ;Žuvela, Marinko (6602952252) ;Radovanović, Nebojša (57221820776) ;Palibrk, Ivan (6507415211) ;Galun, Danijel (23496063400) ;Matić, Slavko (7004660212) ;Lončar, Zlatibor (26426476500) ;Bojović, Predrag (29367568800) ;Ajdinovic, Boris (24167888800)Obradovic, Vladimir (7003389726)Background/Aim: The aim of this study was to evaluate the clinical reliability of the immunoscintigraphy with radiolabeled monoclonal antibodies for the detection of metastases and recurrences of rectal carcinomas. Methodology: A total of 65 patients underwent immunoscintigraphy with radiolabeled monoclonal antibodies. Indication for that examination was suspicious rectal cancer or suspicious rectal cancer recurrence and/or metastases. Results: The method proved to have 92.7% sensitivity, specificity 83.3%, positive predictive value 90.5%, negative predictive value 87.0% and accuracy 89.2%. There was a statistically significant relationship between immunoscintigraphy findings and rectoscopy findings (rs=0.415, p=0.013), as well as significant relationship between immunoscintigraphy findings and US findings (rs=0.332, p=0.001). Tumor marker levels were in positive correlation with findings of immunoscintigraphy (r s=0.845, p=0.001), especially raised CEA level (rs=0.816, p=0.004). Patients with higher CA19-9 level had higher Duke's stage (p=0.025). Conclusions: We can conclude that immunoscintigraphy can be helpful in the detection of metastases and recurrences of colon carcinomas. © H.G.E. Update Medical Publishing S.A.
